D. Hazelard et al. / Tetrahedron: Asymmetry 15 (2004) 1711–1718
1717
1455, 1167; 1H NMR (CDCl3):
d
1.93 (dddd,
800, k ¼ 0:710693 A (Mo-Ka), l ¼ 0:227 mmꢀ1; 5599
reflections measured (0 6 h 6 10, 0 6 k 6 10, 0 6 l 6 48)
on a Nonius CAD4 diffractometer. The structure was
ꢁ
J ¼ 7:8 Hz, J ¼ 7:3 Hz, J ¼ 10:2 Hz, J ¼ 21:2 Hz, 1H–
C3), 2.29 (dddd, J ¼ 5:4 Hz, J ¼ 8:1 Hz, J ¼ 9:8 Hz,
J ¼ 21:2 Hz, 1H–C3), 2.60–2.91 (m, 2H–C4), 4.70 (m,
like AB system, 2Hbenzyl), 4.60–4.82 (m, 1H–C2), 7.25 (m,
5H); 13C NMR (CDCl3): d 19.5 (C3), 39.1 (C4), 71.9
(C2), 86.9 (Cbenzyl), [6 arom. C: 127.9,127.95 (2C), 128.3
(2C), 137.1], 206.5 (C1). All spectral data are identical
with those reported for the racemic compound.17
27
solved with SIR92 and refined with CRYSTALS.27
Hydrogen atom riding, refinement converged to RðgtÞ ¼
0:0540 for the 1697 reflections having I ¼ 2rðIÞ, and
wRðgtÞ ¼ 0:0565, Goodness-of-Fit S ¼ 1:1037, residual
3
ꢁ
electron density: ꢀ0.35 and 0.35 e A .
4.7.2.
(S)-())-2-Benzyloxycyclobutanone,
(S)-())-9.
Acknowledgements
According to procedure E: From 444 mg (2 mmol) of
dimethyl acetal (S)-(þ)-8a (ee ¼ 98%), we obtained after
FC 320 mg (91%) of benzyloxycyclobutanone (S)-(ꢀ)-9
ꢀ
D.H. and A.F. want to thank Mr. C. Merienne for
assistance with X-ray analysis.
(ee ¼ 98%) ½aꢂ ¼ ꢀ80 (c 1, CHCl3); tR ¼ 143:11 min,
D
(b-cyclodextrine DM, 110 ꢂC/1 bar), and 22 mg of
starting acetal (S)-(þ)-8a. All spectral data are identical
with those reported for the racemic compound.17
References and notes
1. Conia, J.-M.; Sandre, J.-P. Bull. Soc. Chim. Fr. 1963, 744.
2. (a) Vidal, J.; Huet, F. J. Org. Chem. 1988, 53, 611; (b)
Cohen, T.; Ouellette, D.; Senaratne, K. P. A.; Yu, L.-C.
Tetrahedron Lett. 1981, 22, 3377.
3. (a) Shevchuk, T. A.; Kulinkovich, O. G. Russ. J. Org.
Chem. 2000, 36, 491; (b) Wassermann, H. H.; Hearn, M.
J.; Cochoy, R. E. J. Org. Chem. 1980, 45, 2874.
4. For optically active cyclobutanones, see: (a) Fitjer, L.
Cyclobutanes. In Synthesis: by Ring Enlargement. Houben-
Weyl (Methods of Organic Chemistry); de Meijere, A.,
Ed.; Thieme: Stuttgart, 1997; Vol. E 17e, p 251; (b) Cho, S.
Y.; Cha, J. K. Org. Lett. 2000, 2, 1337; (c) Yoshida, M.;
Ismail, M. A. H.; Nemoto, H.; Ihara, M. J. Chem. Soc.,
Perkin Trans. 1 2000, 2629; (d) Nemoto, H.; Miyata, J.;
Hakamata, H.; Fukumoto, K. Tetrahedron Lett. 1995, 36,
1055; (e) Nemoto, H.; Miyata, J.; Hakamata, H.; Nag-
amochi, M.; Fukumoto, K.. Tetrahedron 1995, 51, 5511;
(f) Krief, A.; Ronvaux, A.; Arounarith, T. Tetrahedron
1998, 54, 6903; (g) Rouge, P. D.; Moglioni, A. G.;
4.8. (+)-(2S,20S)-2-[20-(500-Chloro-600-methoxynaphthalen-
200-yl)propionyloxy]cyclobutanone dimethyl acetal, (+)-10
To
a
solution of (S)-(þ)-5-chloro-Naproxen 1121
(120 mg, 0,45 mmol), (þ)-2-hydroxycyclobutanone me-
thyl acetal (þ)-4a (57 mg, 0.43 mmol), and DMAP (cat.
7 mg) in dry CH2Cl2 (4 mL) was added a solution of
dicyclohexylcarbodiimide (DCC), (100 mg, 048 mmol) in
dry CH2Cl2 (4 mL) at 0 ꢂC. The reaction mixture was
allowed to warm to room temperature with stirring for
14 h. The urea formed was filtered off, washed with
CH2Cl2 and the organic layer concentrated under vac-
uum. Silica gel column chromatography (eluent, EtOAc/
petrol ether, 5:95 fi 3/7) gave the corresponding ester
(þ)-10 (137 mg, 84% yield). Crystallisation from ether/
pentane furnished nice colourless crystals. The X-ray
analysis of these crystals showed an (2S,20S) configura-
~
Moltrasio, G. Y.; Ortuno, R. M.. Tetrahedron: Asymmetry
2003, 14, 193; (h) Ollivier, J.; Legros, J.-Y.; Fiaud, J.-C.;
€
de Meijere, A.; Salaun, J.. Tetrahedron Lett. 1990, 31,
4135.
tion.24 ½aꢂ ¼ þ5:4 (c 1, CHCl3); mp 77.9 ꢂC (from ether/
D
pentane); tR ¼ 213:95 min (Cydex B, 180 ꢂC/1.05 bar);
Rf ¼ 0:55 (EtOAc/pentane, 3:7); IR (neat): m 2941 cmꢀ1
,
1735 (C@O), 1630 and 1602 (Naphth), 1276, 1179, 1156,
5. (a) Fadel, A.; Khesrani, A. Tetrahedron: Asymmetry 1998,
9, 305; (b) Fadel, A.; Tesson, N. Eur. J. Org. Chem. 2000,
2153; (c) Tesson, N.; Dorigneux, B.; Fadel, A. Tetrahe-
dron: Asymmetry 2002, 13, 2267.
1
1073; H NMR (CDCl3): d 1.60 (d, J ¼ 7:2 Hz, 3H),
1.66–1.89 (m, 2H–C3), 2.00–2.30 (m, 2H–C4), 3.04 (s,
3H, OCH3 acetal), 3.07 (s, 3H, OCH3 acetal), 3.94 (q,
J ¼ 7:2 Hz, 1H, CHCH3), 4.04 (s, 3H, OCH3), 5.00–5.13
(m, 1H–C2), 7.01 (d, J ¼ 8:9 Hz, 1H), 7.57 (dd,
J ¼ 8:9 Hz, J ¼ 1:5 Hz, 1H), 7.68–7.79 (m, 2H), 8.16 (d,
J ¼ 8:9 Hz, 1H); 13C NMR (CDCl3): d 18.1 (CH3), 21.2
ꢀ
6. Truong, M.; Lecornue, F.; Fadel, A. Tetrahedron: Asym-
metry 2003, 14, 1063, and references cited therein.
€
7. Salaun, J.; Fadel, A.; Conia, J. M. Tetrahedron Lett. 1979,
1429.
ꢂ
8. For specialized books see: (a) Poppe, L.; Novak, L.
Selective Biocatalysis: a Synthetic approach; VCH: Wein-
0
(C3), 26.2 (C4), 44.9 (C2 ), 49.0 (CH3 acetal), 49.3
(CH3 acetal), 56.7 (CH3–O–Ar), 73.1 (C2), 103.6 (C1), [10
Naphth. C:113.7 (d), 116.5 (s), 123.6 (d), 126.1 (d), 127.4
(d), 127.6 (d), 129.3(s)þ, 130.8 (s), 136.0 (s), 152.3 (s,
€
heim, 1992; For reviews see: (b) Boland, W.; Forossl, C.;
Lorenz, M. Synthesis 1991, 1049; (c) Banfi, L.; Guanti, G..
Synthesis 1993, 1029; (d) Azerad, R.. Bull. Soc. Chim. Fr.
1995, 132, 17; (e) Schoffers, E.; Golebiowski, A.; Johnson,
C. R.. Tetrahedron 1996, 52, 3769, and references cited
therein.
C6 )], 178.3 (s, C1 ); ES MS m=z: 401.2 [MþNa]þ; HR
ESþ MS m=z: calcd mass for C20H23ClNaO5: 401.1132.
Found: 401.1135.
00
0
9. Therisod, M.; Klibanov, A. M. J. Am. Chem. Soc. 1986,
108, 5638, and references cited therein.
€
10. (a) Ruhlmann, K. Synthesis 1971, 236, and references cited
4.8.1. X-ray structure analysis of (+)-10.24 Crystal data
for (þ)-(2S,20S)-10: white crystal of 0.20 · 0.25 ·
0.30 mm. C20H23Cl1O5, M ¼ 378:85: orthorhombic sys-
tem, space group P 21, 21, 21 (No. 19), Z ¼ 4, with a ¼
therein; (b) Bloomfield, J. J.; Nelke, J. M. Org. Synth.
1977, 57, 1.
11. (a) Conia, J. M.; Barnier, J. P. Terahedron Lett. 1971,
€
4981; (b) Barnier, J. P.; Denis, J. M.; Salaun, J.; Conia, J.
M. Tetrahedron 1974, 30, 1405.
ꢁ
7:434 (3), b ¼ 7:500 (3), c ¼ 34:260 (4) A, a ¼ b ¼ c ¼
3
90ꢂ, V ¼ 1910:1 (11) A , d ¼ 1:304 g cmꢀ3, F ð000Þ ¼
ꢁ
€
12. Fadel, A.; Yefsah, R.; Salaun, J. Synthesis 1987, 37.